Chester S. Zygmont founded Ooxesis Biotech LLC. Currently, he occupies the position of Chief Financial Officer & Director at Revelation Therapeutics LLC and Chief Financial Officer for Revelation Biosciences, Inc.

In the past he occupied the position of Senior Director-Finance at La Jolla Pharmaceutical Co., Vice President for Symmetry Advisors and Managing Director at Z3 Capital LLC.

Chester S. Zygmont received an undergraduate degree from Eastern University and a graduate degree from Zicklin School of Business.